Juan Carlos H.

Investigation of novel agents for Breast Cancer, Non‑Small Cell Lung Cancer, and other Advanced Solid Tumors.

• Endocrine‑based adjuvant strategies in early‑stage disease
• KRAS‑targeted inhibitors for metastatic lung cancer
• Antibody‑drug conjugates combined with immunotherapy

Emphasis on personalized treatment pathways and biomarker‑driven decision making.

Clinical studies addressing Heart Failure optimization and recovery after device therapy, as well as acute inflammatory cardiac conditions.

• Withdrawal protocols for patients responding to cardiac resynchronization therapy
• Low‑dose colchicine for secondary cardiovascular event reduction
• NSAID versus standard analgesia in Acute Myocarditis

Targets functional improvement and long‑term survival in cardiac populations.

Therapeutic evaluation of treatments for severe respiratory infections and chronic airway disease.

• Inhaled triple‑therapy comparison for uncontrolled asthma
• Vaccine efficacy against Community‑Acquired Pneumonia and Pneumococcal Disease
• Antiviral and immunomodulatory regimens in high‑risk pneumonia cohorts

Integrates acute care and preventive vaccination strategies.

Focused on optimizing prophylactic approaches for Preeclampsia in high‑risk pregnancies.

• Aspirin timing strategies to reduce preterm onset
• Risk stratification models incorporating maternal biomarkers
• Comparative outcomes of early versus extended prophylaxis

Aims to improve maternal and neonatal health through evidence‑based prevention.